Reham Abdelkader | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Reham Abdelkader | Pharmacology | Best Researcher Award 

Head of department | German university in Cairo | Egypt

Dr. Reham Mahmoud Abdel-Kader, Professor of Pharmacology and Toxicology and Chair of the Department at the German University in Cairo, is a distinguished biomedical scientist whose research bridges molecular pharmacology, neurodegenerative diseases, and cancer biology with translational therapeutic innovation. Her scientific contributions focus on elucidating mitochondrial dysfunction, neuroinflammation, and cellular bioenergetics as critical mechanisms in Alzheimer’s disease and oncological disorders, advancing targeted treatment approaches through nanotechnology and pharmacogenomic insights. Dr. Abdel-Kader has established two active research groups investigating Alzheimer’s pathology and mitochondrial roles in breast cancer progression, fostering a strong translational link between bench discovery and therapeutic development. She has published widely in internationally recognized journals in pharmacology, neurobiology, and molecular medicine, and her work has received global recognition through prestigious conference presentations and features in leading scientific outlets. Her research has attracted significant international funding from agencies such as the Swiss National Science Foundation, DAAD-BMBF, and the Science and Technology Development Fund, reflecting the impact and sustainability of her scientific endeavors. A committed academic leader, she has played a vital role in curriculum development, accreditation processes, and capacity-building initiatives that enhance educational quality and research excellence within her institution. Dr. Abdel-Kader actively collaborates with leading scientists and institutions across Europe, including partnerships in Germany and Switzerland, fostering international scientific exchange and innovation. Her patent in nanocomposite synthesis further underscores her commitment to bridging pharmaceutical research and technology-based solutions. Through her scholarly rigor, mentorship, and collaborative leadership, Dr. Abdel-Kader continues to contribute significantly to global pharmacological sciences and to shaping the next generation of health researchers dedicated to advancing human health and societal well-being.

Profiles: Google Scholar | ORCID

Publications

1. Leuner, K., Hauptmann, S., Abdel-Kader, R., Scherping, I., Keil, U., & others. (2007). Mitochondrial dysfunction: The first domino in brain aging and Alzheimer’s disease? Antioxidants & Redox Signaling,

2. Abdel-Kader, R., Hauptmann, S., Keil, U., Scherping, I., Leuner, K., Eckert, A., & others. (2007). Stabilization of mitochondrial function by Ginkgo biloba extract (EGb 761). Pharmacological Research,

3. Eckert, G. P., Renner, K., Eckert, S. H., Eckmann, J., Hagl, S., Abdel-Kader, R. M., & others. (2012). Mitochondrial dysfunction—A pharmacological target in Alzheimer’s disease. Molecular Neurobiology,

4. Franke, C., Nöldner, M., Abdel-Kader, R., Johnson-Anuna, L. N., Wood, W. G., & others. (2007). Bcl-2 upregulation and neuroprotection in guinea pig brain following chronic simvastatin treatment. Neurobiology of Disease

5. Eckert, G. P., Schiborr, C., Hagl, S., Abdel-Kader, R., Müller, W. E., & Rimbach, G. (2013). Curcumin prevents mitochondrial dysfunction in the brain of the senescence-accelerated mouse-prone 8. Neurochemistry International.

Maxim Evstigneev | Pharmacology | Best Researcher Award

Published on by Health Scientists

Prof. Dr. Maxim Evstigneev | Pharmacology | Best Researcher Award 

Director | Sevastopol State University | Russia

Dr. Maxim Pavlovich Evstigneev is the Director of the Institute for Advanced Studies at Sevastopol State University, Russian Federation. He earned his Ph.D. and Doctor of Science (DrSci) in Biophysics and was later appointed Full Professor of Physics. Dr. Evstigneev’s research focuses on the thermodynamics of drug interactions, biophysical chemistry, and nanoparticle interactions, with pioneering contributions in understanding DNA-binding drug mechanisms and the biomedical potential of C60 fullerenes. He has authored numerous peer-reviewed journal articles and several scientific books, including DNA-binding Aromatic Drug Molecules: Physico-chemical Interactions and Their Biological Roles and Structure, Thermodynamics and Energetics of Drug-DNA Interactions. His scientific impact is reflected through extensive citations and global recognition. Dr. Evstigneev has received multiple prestigious honors, including awards from the Cabinet of Ministers of Ukraine, the President of Ukraine Award to Young Scientists, and recognition as the youngest Doctor of Sciences in Ukraine. He has also led several national and international research grants supported by major scientific foundations and institutions. Beyond research, he serves as Guest Editor for Organic Chemistry International Journal and was an Editorial Board Member of BioMed Research International. Currently, he is Vice-President of the Crimean Academy of Sciences and a recognized expert for the Russian Academy of Sciences, exemplifying leadership and excellence in molecular biophysics and nanomaterials research. He has 2564 citations from 191 documents with an h-index of 28.

Profiles: Google Scholar | Scopus

Publications

1. The Fundamental Origin of the Polar Contribution to Heat Capacity Changes in Hydration in an Aqueous Solution. (2025). Journal of Physical Organic Chemistry.

2. The Correlated States Theory of the Hydrophobic Effect. (2025). Journal of Physical Chemistry B.

3. Valsartan – Choline: Preparation, Characterization, and Transdermal Permeation. (2025). Journal of Molecular Liquids.

4. Rationalizing DLS Size Distributions of Fullerene Conjugates. (2024). Letter Article.

5.New PMMA-Based Hydroxyapatite/ZnFe₂O₄/ZnO Composite with Antibacterial Performance and Low Toxicity. (2023). Biomimetics.

Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Published on by Health Scientists

Assist. Prof. Dr. Milad Rahimzadegan | Pharmacology | Best Academic Researcher Award

Assistant Professor | Shahid Beheshti University of Medical Sciences | Iran

Dr. Milad Rahimzadegan is an Assistant Professor at the Functional Neurosurgery Research Center, Shahid Beheshti University of Medical Sciences, and serves as R&D Manager in multiple pharmaceutical companies. He earned his PhD in Pharmacy-Toxicology and Pharmacology from Tehran University of Medical Sciences, followed by an M.Sc. in Medical Toxicology from Tarbiat Modares University, and a B.A. in Plant Medicine from the University of Tehran. Recently, he completed a post-doctoral fellowship focused on Artificial Intelligence in Neuroscience at the Functional Neurosurgery Research Center. Dr. Rahimzadegan’s research spans neuropharmacology, neurotoxicology, regenerative medicine, and advanced drug delivery systems, with particular emphasis on stem cell differentiation, conductive scaffolds for spinal cord injury, and nano-biosensing for cardiovascular and neurodegenerative diseases. He has authored numerous high-impact publications in journals including Stem Cell Reviews and Reports, International Journal of Biological Macromolecules, Materials Science & Engineering C, and Carbohydrate Polymers, and has contributed to multiple books on pharmacology, regenerative medicine, and neurosurgery. His work has been recognized with awards such as the Top Academic Secretary of USERN Iran, Young Scientific Award at Shahid Beheshti University, and membership in Iran’s National Elites Foundation. In addition to his research contributions, he serves as a reviewer and editorial board member for journals including Interventional Pain Medicine and Neuromodulation and International Clinical Neuroscience Journal, reflecting his commitment to advancing scientific knowledge and fostering innovation in neuroscience, pharmacology, and translational medicine. He has 326 citations from 26 documents with an h-index of 11.

Profiles: Google Scholar | Scopus | ORCID

Publications

1. Rahimzadegan, M., & Soodi, M. (2018). Comparison of memory impairment and oxidative stress following single or repeated doses administration of scopolamine in rat hippocampus.

2. Asl, S. K., & Rahimzadegan, M. (2022). The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.

3. Malek-Khatabi, A., Razavi, M. S., Abdollahi, A., & Rahimzadeghan, M., et al. (2023). Recent progress in PLGA-based microneedle-mediated transdermal drug and vaccine delivery.

4. Asl, S. K., Rahimzadegan, M., & Asl, A. K. (2024). Progress in cardiac tissue engineering and regeneration: Implications of gelatin-based hybrid scaffolds.

5. Asl, S. K., Rahimzadegan, M., & Ostadrahimi, R. (2024). The recent advancement in the chitosan hybrid-based scaffolds for cardiac regeneration after myocardial infarction.